WO2013084070A3 - Salmonella vaccine proteins - Google Patents
Salmonella vaccine proteins Download PDFInfo
- Publication number
- WO2013084070A3 WO2013084070A3 PCT/IB2012/002944 IB2012002944W WO2013084070A3 WO 2013084070 A3 WO2013084070 A3 WO 2013084070A3 IB 2012002944 W IB2012002944 W IB 2012002944W WO 2013084070 A3 WO2013084070 A3 WO 2013084070A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- infection
- salmonella spp
- salmonella vaccine
- vaccine proteins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Compositions and methods for the treatment or prevention of Gram negative bacterial, such as Salmonella spp. infection, in a vertebrate subject are provided. The methods provide administering a composition to the vertebrate subject in an amount effective to reduce or eliminate the Salmonella spp. bacterial infection and/or induce an immune response to the protein. Methods for the treatment or prevention of Salmonella spp. infection in a vertebrate are also provided. Other compositions and methods are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161567526P | 2011-12-06 | 2011-12-06 | |
US61/567,526 | 2011-12-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013084070A2 WO2013084070A2 (en) | 2013-06-13 |
WO2013084070A3 true WO2013084070A3 (en) | 2013-08-08 |
Family
ID=48575011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2012/002944 WO2013084070A2 (en) | 2011-12-06 | 2012-12-06 | Salmonella vaccine proteins |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013084070A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103558388B (en) * | 2013-10-24 | 2015-06-10 | 江南大学 | Double-antibody sandwich method for detecting salmonella typhimurium in food based on monoclonal antibodies |
CN104792991B (en) * | 2015-04-17 | 2016-08-17 | 江南大学 | The specific diabodies sandwich assay that a kind of detection Salmonella in Food based on monoclonal antibody belongs to |
US11236135B2 (en) | 2017-04-27 | 2022-02-01 | Helmholtz-Zentrum Fur Infektionsforschung Gmbh | Salmonella and immunogenic composition containing the same as well as its use |
US11123415B2 (en) | 2017-08-16 | 2021-09-21 | Ohio State Innovation Foundation | Nanoparticle compositions for Salmonella vaccines |
-
2012
- 2012-12-06 WO PCT/IB2012/002944 patent/WO2013084070A2/en active Application Filing
Non-Patent Citations (2)
Title |
---|
GIL-CRUZ ET AL.: "The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response", PNAS, vol. 106, June 2009 (2009-06-01), pages 9803 - 9808, XP002564409 * |
SIMON ET AL.: "Salmonella enterica serovar enteritidis core 0 polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis", INFECTION AND IMMUNITY, vol. 79, October 2011 (2011-10-01), pages 4240 - 4249, XP002675655 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013084070A2 (en) | 2013-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
WO2012092469A3 (en) | Clostridium difficile antigens | |
SG10201804809RA (en) | Clostridium difficile antibodies | |
WO2012097185A3 (en) | Omv vaccine against burkholderia infections | |
WO2012145491A3 (en) | Composition and method for enhancing an immune response | |
MX350325B (en) | Bacterium for use as a probiotic for nutritional and medical applications. | |
WO2011152566A3 (en) | Composition for inducing proliferation or accumulation of regulatory t cells | |
WO2012072713A3 (en) | Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae | |
MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
AU2018256482A1 (en) | Antibodies Against Clostridium Difficile | |
IN2012DN01898A (en) | ||
WO2012145651A3 (en) | Compounds for the treatment of neuropsychiatric disorders | |
WO2013059559A3 (en) | Compounds and methods for enhancing innate immune responses | |
MX366368B (en) | Prebiotic oral care methods using a saccharide. | |
WO2012023051A3 (en) | Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder | |
UA111599C2 (en) | COMPOSITION OF CASPOFUNGIN | |
WO2013106689A8 (en) | Hcv ns3 protease inhibitors | |
WO2012061248A8 (en) | Novel specific hcv ns3 protease inhibitors | |
WO2013084070A3 (en) | Salmonella vaccine proteins | |
WO2012151279A3 (en) | Induction of il-12 using immunotherapy | |
WO2009115509A3 (en) | Antigenic protein fragments of streptococcus pneumoniae | |
NZ700467A (en) | Treatments suitable for malassezia infections | |
MX355719B (en) | Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum. | |
WO2014167582A3 (en) | Vaccine composition for prophylaxis in ruminants | |
ZA201308256B (en) | Uses, methods and biological compositions of the genus paecilomyces for the control, prevention and eradication of phytoparasites in solanaceae cultures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12856428 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12856428 Country of ref document: EP Kind code of ref document: A2 |